Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab

Journal of Oncology Pharmacy Practice

Impact Factor: 1.3 / 5-Year Impact Factor: 1.3

Journal Homepage Submission guidelines

Restricted access

Letter

First published online June, 2021

Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab

, , [...], and

Volume 27, Issue 4

https://doi.org/10.1177/10781552211004694

Abstract

Get full access to this article

View all access options for this article.

References

Pampín-Sánchez

Barbazán-Vázquez

Fernández-González

, et al. Long-term response control in a patient with metastatic squamous cell lung cancer after treatment with nivolumab: a case report. J Oncol Pharm Pract 2020; 26: 1802–1806.

Perrier

Didelot

Laurent-Puig

, et al. Epigenetic mechanisms of resistance to immune checkpoint inhibitors. Biomolecules 2020; 10: 1061.

Browse journal

Current issue OnlineFirst All issues